Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial

Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial

Visceral leishmaniasis (VL) is a parasitic disease with about 500,000 new cases each year and is fatal if untreated. The current standard therapy involves long courses, has toxicity and there is evidence of increasing resistance. New and better treatment options are urgently needed. Recently, the an...

Full description

Bibliographic Details
Main Authors: Musa, Ahmed, Khalil, Eltahir, Hailu, Asrat, Olobo, Joseph, Balasegaram, Manica, Omollo, Raymond, Edwards, Tansy, Rashid, Juma, Mbui, Jane, Musa, Brima, Abuzaid, Abuzaid Abdalla, Ahmed, Osama, Fadlalla, Ahmed, El-Hassan, Ahmed, Mueller, Marius, Mucee, Geoffrey, Njoroge, Simon, Manduku, Veronica, Mutuma, Geoffrey, Apadet, Lilian, Lodenyo, Hudson, Mutea, Dedan, Kirigi, George, Yifru, Sisay, Mengistu, Getahun, Hurissa, Zewdu, Hailu, Workagegnehu, Weldegebreal, Teklu, Tafes, Hailemariam, Mekonnen, Yalemtsehay, Makonnen, Eyasu, Ndegwa, Serah, Sagaki, Patrick, Kimutai, Robert, Kesusu, Josephine, Owiti, Rhoda, Ellis, Sally, Wasunna, Monique
Format: Online
Language:English
Published: Public Library of Science 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378617/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378617/

Similar Items